Covid-19 a brief Overview
DOI:
https://doi.org/10.47709/brilliance.v2i3.1601Keywords:
COVID-19, SARS-CoV-2, coronavirus, diseaseAbstract
In December 2019, pneumonia brought on by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection first appeared in Wuhan City, Hubei Province, China. The World Health Organization (WHO) will formally refer to the illness brought on by SARS-CoV-2 infection as coronavirus disease by February 11, 2020. (COVID-19). Fever, a dry cough, and exhaustion are the most common clinical symptoms of COVID-19, and pulmonary involvement is often evident. Being extremely infectious, SARS-CoV-2 may infect the majority of people in the general population. Currently, the major sources of the illness, which is spread by respiratory droplets and direct contact, are infected individuals and wild animal hosts. Since the outbreak, the Chinese government and scientific community have moved quickly to uncover the underlying cause, disclose the viral DNA sequence, and implement control measures. While past studies have concentrated on epidemiology, clinical characteristics, diagnosis, treatment, as well as the development of drugs and vaccines, current research has uncovered crucial parts of SARS-CoV-2 biology and disease pathogenesis. This review tries to establish agreement among experts by summarising the most recent study results. Along with current advice for prevention, containment, and essential treatment of this pandemic, we will also discuss existing initiatives and experience from China that may provide light on how to curb the outbreak and further our knowledge of this newly emergent infectious illness.
References
Agostini ML, Andres EL, Sims AC, et al., 2018. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio, 9(2):e00221-18. https://doi.org/10.1128/mBio.00221-18
Al-Awkally, Noor-Alhooda Milood, Hamza Khalifa Ibrahim, and Abdul Samad. "Antipsychotic Combinations for Psychiatric Disorders." BULLET: Jurnal Multidisiplin Ilmu 1.01 (2022): 49-50
Al-Tawfiq JA, Alfaraj SH, Altuwaijri TA, et al., 2017. A cohort-study of patients suspected for MERS-CoV in a referral hospital in Saudi Arabia. J Infect, 75(4):378-379. https://doi.org/10.1016/j.jinf.2017.06.002
Arabi Y, Balkhy H, Hajeer AH, et al., 2015. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. SpringerPlus,4:709. https://doi.org/10.1186/s40064-015-1490-9
Arif, S., Zia, T., Mustafa, G., Qayyum, Z., Ateeq, M., Faiz, M. J., ... & Ullah, I. (2022). Knowledge, Attitude and Practices of Medical Students Regarding Covid-19, Pakistan. Pakistan Journal of Medical & Health Sciences, 16(03), 783-783.
Arif, S., Zia, T., Qayyum, Z., Mustafa, G., Ateeq, M., Farhad, S., ... & Muthanna, F. M. (2022). Prevalence and Risk Factors of Covid-19 Mortality and its Impact on Social Life of Pakistani Population. Pakistan Journal of Medical & Health Sciences, 16(03), 800-800.
Asselah T, Benhamou Y, Marcellin P, 2009. Protease and polymerase inhibitors for the treatment of hepatitis C. Liver Int, 29(S1):57-67. https://doi.org/10.1111/j.1478-3231.2008.01928.x
Badgett MR, Auer A, Carmichaelary dynamics of viral attenuation. LE, et al., 2002. EvolutionJ Virol,76(20):10524- 10529. https://doi.org/10.1128/jvi.76.20.10524-10529.2002
Bao YP, Sun YK, Meng SQ, et al., 2020. 2019-nCoV epidemic: address mental health care to empower society. Lancet, 395(10224):E37-E38. https://doi.org/10.1016/s0140-6736(20)30309-3
Brown AJ, Won JJ, Graham RL, et al., 2019. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res, 169:104541. https://doi.org/10.1016/j.antiviral.2019.104541
Ceraolo C, Giorgi FM, 2020. Genomic variance of the 2019- nCoV coronavirus. J Med Virol, 92(5):522-528. https://doi.org/10.1002/jmv.25700
Chan JFW, Kok KH, Zhu Z, et al., 2020b. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect, 9(1):221-236. https://doi.org/10.1080/22221751.2020.1719902
Chan JFW, Yuan SF, Kok KH, et al., 2020a. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 395(10223):514-523. https://doi.org/10.1016/S0140-6736(20)30154-9
Chen HJ, Guo JJ, Wang C, et al., 2020. Clinical characteristics and intrauterine vertical transmission potential of COVID-19infection in nine pregnant women: a retrospective review of medical records. Lancet, 395(10226):809-815. https://doi.org/10.1016/s0140-6736(20)30360-3
Chen LJ, Liu WY, Zhang Q, et al., 2020. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect, 9(1):313-319. https://doi.org/10.1080/22221751.2020.1725399
Chen NS, Zhou M, Dong X, et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223):507-513. https://doi.org/10.1016/s0140-6736(20)30211-7
Chu CM, Cheng VCC, Hung IFN, et al., 2004. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax, 59(3):252-256. https://doi.org/10.1136/thorax.2003.012658
Cui HZ, Gao ZY, Liu M, et al., 2020. Structural genomics and interactomics of 2019 Wuhan novel coronavirus, 2019- nCoV, indicate evolutionary conserved functional regions of viral proteins. bioRxiv, preprint. https://doi.org/10.1101/2020.02.10.942136
Cui QH, Huang CB, Ji XW, et al., 2020. Possible inhibitors of ACE2, the receptor of 2019-nCoV. Preprints, 2020020047. https://doi.org/10.20944/Preprints202002.0047.V1
Cyranoski D, 2020. When will the coronavirus outbreak peak? Nature, Feb. 18, 2020. https://doi.org/10.1038/d41586-020-00361-5
de Wit E, van Doremalen N, Falzarano D, et al., 2016. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol, 14(8):523-534. https://doi.org/10.1038/nrmicro.2016.81
Dong N, Yang XM, Ye LM, et al., 2020. Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China. bioRxiv, preprint. https://doi.org/10.1101/2020.01.20.913368
Drosten C, Günther S, Preiser W, et al., 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med, 348(20):1967-1976. https://doi.org/10.1056/NEJMoa030747
Fan W, Yang C, Cui M, 2020. The first doctor to report the epidemic: “I realized that something was wrong and I started to prepare.” people.cn. http://society.people.com.cn/ n1/2020/0207/c1008-31575058.html [Accessed on Feb. 28, 2020] (in Chinese).
Fang Q, 2020. Nan-shan ZHONG’s team isolated the neocorona virus from a patient’s urine specimen. Guangzhou Daily. https://gzdaily.dayoo.com/pc/html/2020-02/23/content_127574_683801.htm [Accessed on Feb. 28, 2020] (in Chinese).
Favre G, Pomar L, Musso D, et al., 2020. 2019-nCoV epidemic: what about pregnancies? Lancet, 389(10224):E40. https://doi.org/10.1016/s0140-6736(20)30311-1
Gallagher TM, Buchmeier MJ, 2001. Coronavirus spike proteins in viral entry and pathogenesis. Virology, 279(2): 371-374. https://doi.org/10.1006/viro.2000.0757
Gao S, Song SQ, Zhang LL, 2019. Recent progress in vaccine development against chikungunya virus. Front Microbiol, 10:2881. https://doi.org/10.3389/fmicb.2019.02881
General Office of National Health Commission of the People’s Republic of China, 2020. Diagnosis and treatment for novel coronavirus (Version 5). http://www.nhc.gov.cn/ xcs/zhengcwj/202002/3b09b894ac9b4204a79db5b8912d4440.shtml [Accessed on Feb. 28, 2020] (in Chinese).
Guan WJ, Ni ZY, Hu Y, et al., 2020. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, in press. https://doi.org/10.1056/NEJMoa2002032
Guo Q, Li M, Wang CH, et al., 2020. Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm. bioRxiv, preprint.
Heurich A, Hofmann-Winkler H, Gierer S, et al., 2014. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol, 88(2):1293-1307. https://doi.org/10.1128/JVI.02202-13
Hoffmann M, Kleine-Weber H, Krüger N, et al., 2020. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv, preprint. https://doi.org/10.1101/2020.01.31.929042
Hofmann H, Pöhlmann S, 2004. Cellular entry of the SARS coronavirus. Trends Microbiol, 12(10):466-472. https://doi.org/10.1016/j.tim.2004.08.008 Huang CL, Wang YM, Li XW, et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506. https://doi.org/10.1016/s0140-6736(20)30183-5
https://doi.org/10.1101/2020.01.21.914044 He YX, Jiang SB, 2005. Vaccine design for severe acute respiratory syndrome coronavirus. Viral Immunol, 18(2): 327-332. https://doi.org/10.1089/vim.2005.18.327
Huang Q, Herrmann A, 2020. Fast assessment of human receptor-binding capability of 2019 novel coronavirus (2019-nCoV). bioRxiv, preprint. https://doi.org/10.1101/2020.02.01.930537
Ibrahim, H. K., Al-Awkally, N. A. M., Samad, A., Zaib, W., & Hamza, M. (2022). Covid-19 Pandemic and Its Impact on Psychological Distress, Malignancy and Chronic Diseases: A Scoping Review. Eduvest-Journal Of Universal Studies, 2(5), 1017-1021.
Jaimes JA, André NM, Millet JK, et al., 2020. Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses. bioRxiv, preprint. https://doi.org/10.1101/2020.02.10.942185
Ji W, Wang W, Zhao XF, et al., 2020. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol, 92(4):433-440. https://doi.org/10.1002/jmv.25682
Mohammed, A. A., Samad, A., & Omar, O. A. (2022). Escherichia coli spp, Staph albus and Klebseilla spp were affected by some Antibiotics for Urinary Tract Infections in Bani Waleed City. Brilliance: Research of Artificial Intelligence, 2(2), 66-70.
Muthanna, F. M., & Samad, A. (2022). Covid-19 Pendemic (Incidence, Risk factors and Treatment). BULLET: Jurnal Multidisiplin Ilmu, 1(01), 46-48.
Muthanna, F. M., Ibrahim, H. K., Al-Awkally, N.-A. M., Yousuf, A., & Mounich, K. (2022). C-reactive protein in patients with COVID-19: A scoping review. International Journal of Health Sciences, 6(S5), 1610–1620. https://doi.org/10.53730/ijhs.v6nS5.8920
Muthanna, F. M., Samad, A., Ibrahim, H. K., Al-Awkally, N. A. M., & Sabir, S. (2022). Cancer related anaemia (CRA): An overview of approach and treatment. International Journal of Health Sciences, 6, 2552-2558.
Samad A, Abbas A, Mehtab U, Ur Rehman Ali Khera H, Rehman A and Hamza M . Infectious Bronchitis Disease in Poultry its Diagnosis, Prevention and Control Strategies. Ann Agric Crop Sci. 2021; 6(7): 1100.
Samad, A. ., Hamza , M., Muazzam, A. ., Ahmad, H. ., Ahmer, A. ., Tariq, S. ., Khera, H. U. R. A. ., Mehtab, U. ., Shahid, M. J. ., Akram, W. ., Kaleem, M. Z. ., Ahmad, S. ., Abdullah, A. ., & Ahmad, S. . (2022). Policy of control and prevention of infectious bursal disease at poultry farm. African Journal of Biological, Chemical and Physical Sciences, 1(1), 1-7.
Samad, A., Ahmad, H., Hamza, M., Muazzam, A., Ahmer, A., Tariq, S & Muthanna, F. M. (2022). Overview of Avian Corona virus, its prevention and control Measures. BULLET: Jurnal Multidisiplin Ilmu, 1(01), 39-45.
Samad, A., Hamza, M., Muazzam, A., Ahmer, A., Tariq, S., Javaid, A., ... & Ahmad, S. (2022). Newcastle Disease In Poultry, Its Diagnosis, Prevention And Control Strategies. BULLET: Jurnal Multidisiplin Ilmu, 1(01), 1-5.
Samad, A., Hamza, M., Muazzam, A., Ahmer, A., Tariq, S., Shahid, M. J., ... & Din, F. U. (2022). Overview of Bacterial Diseases in Poultry and policies to control disease and antibiotic resistance. BULLET: Jurnal Multidisiplin Ilmu, 1(01), 19-25.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sania Tariq, Muhammad Hamza, Ayesha Muazzam, Areeb Ahmer, M.Talha Mumtaz, Shehroz Ahmad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
info@itscience.org, web: 
